279 filings
Page 5 of 14
4
qysq8k
6 Jan 20
Deciphera Pharmaceuticals / Christopher John Morl ownership change
4:15pm
4
wjev3
6 Jan 20
Deciphera Pharmaceuticals / Thomas Patrick Kelly ownership change
4:15pm
4
pcpz y49iti6mwh
6 Jan 20
Deciphera Pharmaceuticals / James Arthur Bristol ownership change
4:15pm
4
354 mkq7t9kf6c
26 Dec 19
Deciphera Pharmaceuticals / Thomas Patrick Kelly ownership change
4:05pm
8-K
tev bs4uc
16 Dec 19
Deciphera Pharmaceuticals Announces Submission of New Drug Application to U.S. FDA for Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors
7:08am
4
84a65e wv
13 Dec 19
Deciphera Pharmaceuticals / Christopher John Morl ownership change
5:00pm
4
19qih
13 Dec 19
Deciphera Pharmaceuticals / Daniel Lee Flynn ownership change
5:00pm
4
ewnin pdh
11 Dec 19
Deciphera Pharmaceuticals / Christopher John Morl ownership change
4:30pm
4
wesj f8pcaahz
11 Dec 19
Deciphera Pharmaceuticals / Daniel Lee Flynn ownership change
4:10pm
4
d40aqva
6 Dec 19
Deciphera Pharmaceuticals / Ron Squarer ownership change
4:09pm
3
xzh8x
6 Dec 19
Deciphera Pharmaceuticals / Ron Squarer ownership change
4:05pm
4
fp1 jzl1q7j59vu
5 Dec 19
Deciphera Pharmaceuticals / Christopher John Morl ownership change
4:20pm
8-K
yq8c8owak9vz4m1s
4 Dec 19
Departure of Directors or Certain Officers
4:13pm
4
rpabdp2eqnwsit
26 Nov 19
Deciphera Pharmaceuticals / Franklin Stuart Friedman ownership change
4:45pm
3
qgi3j5f 71e8u
26 Nov 19
Deciphera Pharmaceuticals / Franklin Stuart Friedman ownership change
4:34pm
8-K
y6fm0 1dol0w2bsl
26 Nov 19
Departure of Directors or Certain Officers
8:17am
SC 13D/A
crci7t8t69c
15 Nov 19
Deciphera Pharmaceuticals, Inc.
4:24pm
4
cxb0p4sf
13 Nov 19
Deciphera Pharmaceuticals / Daniel Lee Flynn ownership change
4:59pm
8-K
rkc3lohj5x
13 Nov 19
Deciphera Pharmaceuticals, Inc. to Present Data fromDCC-3014 and Ripretinib Programs at the Connective Tissue Oncology Society (CTOS) 2019 Annual Meeting
4:41pm
4
wig oquc3zqt3g8l
5 Nov 19
Deciphera Pharmaceuticals / James Arthur Bristol ownership change
12:00am